Antigenic evidence of prevalence and diversity of Mycobacterium tuberculosis arabinomannan

Aharona Glatman-Freedman, Arturo Casadevall, Zongdong Dai, William R. Jacobs, Anping Li, Sheldon L. Morris, Josepine Anne D Navoa, Sajida Piperdi, John B. Robbins, Rachel Schneerson, J. Reid Schwebach, Michael Shapiro

Research output: Contribution to journalArticle

Abstract

Arabinomannan (AM) is a polysaccharide of the mycobacterial capsule. The capsular polysaccharides of various microorganisms are diverse, and this diversity is important for classification of organisms into serotypes and vaccine development. In the present study we examined the prevalence and diversity of AM among Mycobacterium tuberculosis strains using four AM-binding monoclonal antibodies (MAbs). One of these MAbs, MAb 9d8, is known to bind to AM specifically. By whole-cell enzyme-linked immunosorbent assay (ELISA), the AM recognized by MAb 9d8 was detected on the surfaces of 9 of 11 strains, while 2 strains showed no reactivity with MAb 9d8. However, the AM recognized by MAb 9d8 was found in the culture supernatants of all 11 M. tuberculosis strains tested, as demonstrated by capture ELISA. Other AM-binding MAbs reacted both with the surfaces and with the culture supernatants of all 11 strains. Mice immunized with an experimental AM-recombinant Pseudomonas aeruginosa exoprotein A (rEPA) conjugate vaccine had an increased antibody response to AM and a moderate reduction in the numbers of CFU in their organs 7 days after challenge. Our results indicate that AM was detected in all M. tuberculosis strains tested, with differences in epitope distributions of certain strains. In addition, our results suggest that an experimental AM-rEPA vaccine has a moderate effect on the numbers of CFU in organs early after infection.

Original languageEnglish (US)
Pages (from-to)3225-3231
Number of pages7
JournalJournal of Clinical Microbiology
Volume42
Issue number7
DOIs
StatePublished - Jul 2004
Externally publishedYes

Fingerprint

Mycobacterium tuberculosis
Monoclonal Antibodies
Polysaccharides
arabinomannan
Vaccines
Enzyme-Linked Immunosorbent Assay
Conjugate Vaccines
Pseudomonas aeruginosa
Capsules
Antibody Formation
Epitopes
Cross-Sectional Studies

ASJC Scopus subject areas

  • Microbiology (medical)
  • Microbiology

Cite this

Antigenic evidence of prevalence and diversity of Mycobacterium tuberculosis arabinomannan. / Glatman-Freedman, Aharona; Casadevall, Arturo; Dai, Zongdong; Jacobs, William R.; Li, Anping; Morris, Sheldon L.; Navoa, Josepine Anne D; Piperdi, Sajida; Robbins, John B.; Schneerson, Rachel; Schwebach, J. Reid; Shapiro, Michael.

In: Journal of Clinical Microbiology, Vol. 42, No. 7, 07.2004, p. 3225-3231.

Research output: Contribution to journalArticle

Glatman-Freedman, A, Casadevall, A, Dai, Z, Jacobs, WR, Li, A, Morris, SL, Navoa, JAD, Piperdi, S, Robbins, JB, Schneerson, R, Schwebach, JR & Shapiro, M 2004, 'Antigenic evidence of prevalence and diversity of Mycobacterium tuberculosis arabinomannan', Journal of Clinical Microbiology, vol. 42, no. 7, pp. 3225-3231. https://doi.org/10.1128/JCM.42.7.3225-3231.2004
Glatman-Freedman, Aharona ; Casadevall, Arturo ; Dai, Zongdong ; Jacobs, William R. ; Li, Anping ; Morris, Sheldon L. ; Navoa, Josepine Anne D ; Piperdi, Sajida ; Robbins, John B. ; Schneerson, Rachel ; Schwebach, J. Reid ; Shapiro, Michael. / Antigenic evidence of prevalence and diversity of Mycobacterium tuberculosis arabinomannan. In: Journal of Clinical Microbiology. 2004 ; Vol. 42, No. 7. pp. 3225-3231.
@article{029c0d1d5fa74a139dadff562768817c,
title = "Antigenic evidence of prevalence and diversity of Mycobacterium tuberculosis arabinomannan",
abstract = "Arabinomannan (AM) is a polysaccharide of the mycobacterial capsule. The capsular polysaccharides of various microorganisms are diverse, and this diversity is important for classification of organisms into serotypes and vaccine development. In the present study we examined the prevalence and diversity of AM among Mycobacterium tuberculosis strains using four AM-binding monoclonal antibodies (MAbs). One of these MAbs, MAb 9d8, is known to bind to AM specifically. By whole-cell enzyme-linked immunosorbent assay (ELISA), the AM recognized by MAb 9d8 was detected on the surfaces of 9 of 11 strains, while 2 strains showed no reactivity with MAb 9d8. However, the AM recognized by MAb 9d8 was found in the culture supernatants of all 11 M. tuberculosis strains tested, as demonstrated by capture ELISA. Other AM-binding MAbs reacted both with the surfaces and with the culture supernatants of all 11 strains. Mice immunized with an experimental AM-recombinant Pseudomonas aeruginosa exoprotein A (rEPA) conjugate vaccine had an increased antibody response to AM and a moderate reduction in the numbers of CFU in their organs 7 days after challenge. Our results indicate that AM was detected in all M. tuberculosis strains tested, with differences in epitope distributions of certain strains. In addition, our results suggest that an experimental AM-rEPA vaccine has a moderate effect on the numbers of CFU in organs early after infection.",
author = "Aharona Glatman-Freedman and Arturo Casadevall and Zongdong Dai and Jacobs, {William R.} and Anping Li and Morris, {Sheldon L.} and Navoa, {Josepine Anne D} and Sajida Piperdi and Robbins, {John B.} and Rachel Schneerson and Schwebach, {J. Reid} and Michael Shapiro",
year = "2004",
month = "7",
doi = "10.1128/JCM.42.7.3225-3231.2004",
language = "English (US)",
volume = "42",
pages = "3225--3231",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "7",

}

TY - JOUR

T1 - Antigenic evidence of prevalence and diversity of Mycobacterium tuberculosis arabinomannan

AU - Glatman-Freedman, Aharona

AU - Casadevall, Arturo

AU - Dai, Zongdong

AU - Jacobs, William R.

AU - Li, Anping

AU - Morris, Sheldon L.

AU - Navoa, Josepine Anne D

AU - Piperdi, Sajida

AU - Robbins, John B.

AU - Schneerson, Rachel

AU - Schwebach, J. Reid

AU - Shapiro, Michael

PY - 2004/7

Y1 - 2004/7

N2 - Arabinomannan (AM) is a polysaccharide of the mycobacterial capsule. The capsular polysaccharides of various microorganisms are diverse, and this diversity is important for classification of organisms into serotypes and vaccine development. In the present study we examined the prevalence and diversity of AM among Mycobacterium tuberculosis strains using four AM-binding monoclonal antibodies (MAbs). One of these MAbs, MAb 9d8, is known to bind to AM specifically. By whole-cell enzyme-linked immunosorbent assay (ELISA), the AM recognized by MAb 9d8 was detected on the surfaces of 9 of 11 strains, while 2 strains showed no reactivity with MAb 9d8. However, the AM recognized by MAb 9d8 was found in the culture supernatants of all 11 M. tuberculosis strains tested, as demonstrated by capture ELISA. Other AM-binding MAbs reacted both with the surfaces and with the culture supernatants of all 11 strains. Mice immunized with an experimental AM-recombinant Pseudomonas aeruginosa exoprotein A (rEPA) conjugate vaccine had an increased antibody response to AM and a moderate reduction in the numbers of CFU in their organs 7 days after challenge. Our results indicate that AM was detected in all M. tuberculosis strains tested, with differences in epitope distributions of certain strains. In addition, our results suggest that an experimental AM-rEPA vaccine has a moderate effect on the numbers of CFU in organs early after infection.

AB - Arabinomannan (AM) is a polysaccharide of the mycobacterial capsule. The capsular polysaccharides of various microorganisms are diverse, and this diversity is important for classification of organisms into serotypes and vaccine development. In the present study we examined the prevalence and diversity of AM among Mycobacterium tuberculosis strains using four AM-binding monoclonal antibodies (MAbs). One of these MAbs, MAb 9d8, is known to bind to AM specifically. By whole-cell enzyme-linked immunosorbent assay (ELISA), the AM recognized by MAb 9d8 was detected on the surfaces of 9 of 11 strains, while 2 strains showed no reactivity with MAb 9d8. However, the AM recognized by MAb 9d8 was found in the culture supernatants of all 11 M. tuberculosis strains tested, as demonstrated by capture ELISA. Other AM-binding MAbs reacted both with the surfaces and with the culture supernatants of all 11 strains. Mice immunized with an experimental AM-recombinant Pseudomonas aeruginosa exoprotein A (rEPA) conjugate vaccine had an increased antibody response to AM and a moderate reduction in the numbers of CFU in their organs 7 days after challenge. Our results indicate that AM was detected in all M. tuberculosis strains tested, with differences in epitope distributions of certain strains. In addition, our results suggest that an experimental AM-rEPA vaccine has a moderate effect on the numbers of CFU in organs early after infection.

UR - http://www.scopus.com/inward/record.url?scp=3142708649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142708649&partnerID=8YFLogxK

U2 - 10.1128/JCM.42.7.3225-3231.2004

DO - 10.1128/JCM.42.7.3225-3231.2004

M3 - Article

C2 - 15243086

AN - SCOPUS:3142708649

VL - 42

SP - 3225

EP - 3231

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 7

ER -